BlackRock, Inc. - Mar 31, 2025 SCHEDULE 13G/A Report for Stoke Therapeutics, Inc. Common Stock (STOK)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Stoke Therapeutics, Inc. Common Stock
Symbol: STOK
Shares outstanding: 53.8M shares
Disclosed Ownership: 3.12M shares
Ownership: 5.8%
Form type: SCHEDULE 13G/A
Date filed: 4/16/2025, 06:41 PM
Date of event: Mar 31, 2025
Next filing: Oct 17, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	5.8%	3.12M	3.08M	0	Spencer Fleming	Managing Director